[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100496527":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":12,"locations":22,"responsibleParty":40,"collaborators":10,"id":42,"slug":43,"hasResults":44,"nctId":45,"briefTitle":46,"officialTitle":46,"acronym":10,"eligibilityCriteria":47,"healthyVolunteers":44,"sex":48,"minAge":49,"maxAge":10,"enrollmentInfo":50,"targetDuration":10,"studyType":53,"phases":10,"briefSummary":54,"conditions":55,"keywords":10,"overallStatus":25,"whyStopped":10,"lastUpdateSubmitDate":56,"lastUpdatePostDateStruct":57,"startDateStruct":60,"completionDateStruct":62,"leadSponsor":64,"locationsCount":65},{"fullName":5,"class":6},"CorEvitas","NETWORK",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Alopecia Areata",null,"Pts presenting to enrolling sites across the US are invited to enroll if eligible",[13,18],{"name":14,"role":15,"phone":16,"phoneExt":10,"email":17},"Cathy Cheney","CONTACT","(508) 408-5435","corevitasregistrytrials@corevitas.com",{"name":19,"role":15,"phone":20,"phoneExt":10,"email":21},"Resham Sanzagiri","508-948-0898","regulatory@corevitas.com",[23],{"facility":24,"status":25,"city":26,"state":27,"zip":28,"country":29,"countryCode":30,"cosmosGeoPoint":31,"geoPoint":36,"contacts":37},"CorEvitas, LLC","RECRUITING","Waltham","Massachusetts","02451","United States","US",{"type":32,"coordinates":33},"Point",[34,35],-71.23561,42.37649,{"lat":35,"lon":34},[38],{"name":39,"role":15,"phone":10,"phoneExt":10,"email":17},"Jeffrey Greenberg",{"type":41,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100496527","corevitas-alopecia-areata-aa-safety-and-effectiveness-registry-100496527",false,"NCT05745389","CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry","Inclusion Criteria:\n\n* A subject must meet all the following criteria to participate in the registry:\n\n  1. Has been diagnosed with alopecia areata by a dermatologist or a qualified dermatology practitioner.\n  2. Is at least 18 years of age or older.\n  3. Is willing to provide Personal Information.\n  4. Is prescribed or starting an Enrollment Eligible Medication at the time of enrollment.\n\nExclusion Criteria:\n\n* Any of the following would exclude the subject from participating in the registry:\n\n  1. Is participating or planning to participate in a double-blind randomized trial for an AA drug. Note:\n\nConcurrent participation in another observational registry or open-label Phase 3b\u002F4 trial is allowed.","ALL","18 Years",{"count":51,"type":52},5000,"ESTIMATED","OBSERVATIONAL","Prospective, observational cohort study for subjects with AA under the care of a dermatology provider. Approximately 5,000 subjects and 100 clinical sites in North America will be recruited to participate with no defined upper limit for either target.",[9],"2026-02-05",{"date":58,"type":59},"2026-02-09","ACTUAL",{"date":61,"type":59},"2022-10-25",{"date":63,"type":52},"2099-12-31",{"name":5,"class":6},1]